Tirzepatide (Zepbound / Mounjaro) in McKinney

Typical Tirzepatide (Zepbound / Mounjaro) pricing in McKinney runs $300–$1,100 per month. The biggest variables are the provider's experience level and the specific device or product used. Newer technology and senior injectors price at the upper end. Pricing is quoted in US dollars (USD). Request a consultation from any of our listed McKinney clinics for a personalized quote.

ClinicCompass lists 1 verified McKinney-area clinic offering Tirzepatide (Zepbound / Mounjaro), concentrated in Historic Downtown / Davis Street, Craig Ranch / Collin McKinney Parkway, Virginia Parkway / Stonebridge, Custer Road. Each listing includes real Google ratings so you can compare reputable options side by side before booking a consultation.

Initial results in 2–4 weeks, with full results developing over 3 months as collagen builds. McKinney providers typically schedule follow-ups to track progress.

Maintenance schedules vary. Most McKinney providers recommend periodic refresh sessions every 6–12 months once optimal results are achieved.

Same drug (tirzepatide), different approvals. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is approved for weight loss and obstructive sleep apnea. Weight-loss patients paying cash usually end up with Zepbound, which the manufacturer also sells directly in lower-cost single-dose vials.

On trial averages, yes. SURMOUNT-1 showed ~20–22% average body weight loss at the top dose, and the head-to-head SURMOUNT-5 trial (2025) found tirzepatide patients lost meaningfully more than semaglutide patients (~20% vs ~14%). Averages aren't individuals (plenty of people do great on semaglutide), but if maximum medication effect is the goal, tirzepatide is the current benchmark.

Zepbound lists around $1,100/month, but the manufacturer's direct-to-patient vial program cut cash prices to roughly $349–$499/month depending on dose. Clinic and med spa programs using pharmacy-prepared tirzepatide have typically charged $300–$600/month with supervision included. As with semaglutide, compounding rules tightened after the FDA shortage designation ended. Ask exactly what's being dispensed.

Very similar profile to semaglutide: nausea during dose escalation, constipation or diarrhea, fatigue, reflux. Some patients tolerate tirzepatide's dual mechanism a bit better; others notice no difference. The serious-but-rare list is the same (pancreatitis, gallbladder issues), and the same thyroid-cancer-history exclusions apply. Rapid weight loss also means facial volume loss ('Ozempic face' applies here too), which many patients address with fillers or Sculptra.

The SURMOUNT-4 withdrawal study answered this directly: patients who stopped tirzepatide regained about half the lost weight within a year, while those who continued kept losing. Like all GLP-1s, it's a long-term commitment: plan the maintenance strategy up front.

Consider tirzepatide if: you want the strongest average results, you tried semaglutide with underwhelming effect, or cash price via the manufacturer's vial program beats your semaglutide options. Consider semaglutide if: your insurance covers Wegovy, you want the longest safety track record, or your provider's semaglutide program is meaningfully cheaper. Both beat every weight-loss medication that came before them.